Holen Sie sich die Stockscreener-App
320.27
0.47%
1.50
Vorhandelsmarkt:
320.46
0.19
+0.06%
Schlusskurs vom Vortag:
$318.77
Offen:
$319.48
24-Stunden-Volumen:
601.73K
Relative Volume:
0.98
Marktkapitalisierung:
$22.54B
Einnahmen:
$2.36B
Nettoeinkommen (Verlust:
$236.10M
KGV:
97.47
EPS:
3.286
Netto-Cashflow:
$382.50M
1W Leistung:
-1.25%
1M Leistung:
+3.61%
6M Leistung:
+24.61%
1J Leistung:
+34.88%
1-Tages-Spanne:
$316.37
$322.86
1-Wochen-Bereich:
$309.26
$323.04
52-Wochen-Spanne:
$230.05
$353.50
Insulet Corporation Stock (PODD) Company Profile
Firmenname
Insulet Corporation
Sektor
Branche
Telefon
978-600-7000
Adresse
100 NAGOG PARK, ACTON, MA
Vergleichen Sie PODD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PODD
Insulet Corporation
|
320.27 | 22.44B | 2.36B | 236.10M | 382.50M | 3.286 |
|
ABT
Abbott Laboratories
|
125.80 | 215.34B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.84 | 146.15B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
362.61 | 136.97B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.42 | 115.69B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
84.15 | 48.77B | 5.88B | 1.34B | 577.90M | 2.3455 |
Insulet Corporation Stock (PODD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-21 | Fortgesetzt | Stifel | Buy |
| 2025-09-08 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-06-16 | Eingeleitet | Truist | Buy |
| 2025-05-30 | Eingeleitet | Goldman | Buy |
| 2025-05-13 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-04-29 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2025-03-06 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-11-06 | Eingeleitet | Bernstein | Outperform |
| 2024-05-30 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-05-07 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-12-21 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2023-12-04 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-02 | Hochstufung | Jefferies | Hold → Buy |
| 2023-08-21 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-08-21 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-01-26 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-11-04 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-10-18 | Eingeleitet | Barclays | Equal Weight |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-07-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-02-03 | Hochstufung | BTIG Research | Neutral → Buy |
| 2022-02-02 | Hochstufung | UBS | Neutral → Buy |
| 2022-01-31 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-07-21 | Fortgesetzt | Cowen | Outperform |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-01 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2021-03-19 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2021-01-29 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-12-16 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-07-28 | Eingeleitet | Wells Fargo | Overweight |
| 2020-04-24 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-03 | Eingeleitet | BofA/Merrill | Neutral |
| 2020-03-31 | Herabstufung | Berenberg | Buy → Hold |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2019-12-10 | Eingeleitet | CFRA | Sell |
| 2019-10-23 | Eingeleitet | Stifel | Hold |
| 2019-10-18 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2019-10-14 | Herabstufung | BTIG Research | Buy → Neutral |
| 2019-10-04 | Herabstufung | UBS | Buy → Neutral |
| 2019-10-03 | Herabstufung | Guggenheim | Buy → Neutral |
| 2019-08-06 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2019-06-10 | Herabstufung | Northland Capital | Outperform → Market Perform |
| 2019-05-06 | Hochstufung | BTIG Research | Neutral → Buy |
| 2018-04-20 | Eingeleitet | Berenberg | Buy |
| 2018-02-22 | Bestätigt | Barclays | Overweight |
| 2018-01-08 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2017-11-03 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2017-09-15 | Eingeleitet | Barclays | Overweight |
Alle ansehen
Insulet Corporation Aktie (PODD) Neueste Nachrichten
Advisors Preferred LLC Acquires New Holdings in Insulet Corporation $PODD - MarketBeat
Best data tools to analyze Insulet Corporation stockJuly 2025 Update & AI Driven Stock Reports - newser.com
Is Insulet Corporation stock poised for growthJobs Report & Free Fast Entry Momentum Trade Alerts - newser.com
Why Insulet Corporation (GOV) stock could outperform next yearRate Hike & Technical Confirmation Trade Alerts - newser.com
Will Insulet Corporation stock recover after recent dropMarket Growth Report & Community Verified Trade Alerts - newser.com
Insulet Q3 2025 Earnings: Revenue Forecast & Stock Analysis | PODDNews and Statistics - IndexBox
Earnings To Watch: Insulet (PODD) Reports Q3 Results Tomorrow - FinancialContent
Final Trades: Insulet Corp, Uber and Apollo Global - MSN
Ahead of Insulet (PODD) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics - Yahoo Finance
iA Global Asset Management Inc. Has $1.64 Million Stake in Insulet Corporation $PODD - MarketBeat
What machine learning models say about Insulet CorporationWeekly Risk Report & Free Real-Time Volume Trigger Notifications - newser.com
Why Insulet Corporation (GOV) stock stays resilient2025 Top Decliners & Community Consensus Trade Signals - newser.com
Multi asset correlation models including Insulet CorporationMarket Growth Summary & Stock Portfolio Risk Management - newser.com
Chart based exit strategy for Insulet CorporationFed Meeting & Growth Focused Stock Pick Reports - newser.com
Advanced analytics toolkit walkthrough for Insulet CorporationStock Surge & Expert Curated Trade Setups - newser.com
Insulet Corp. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains - 富途牛牛
[Form 4] INSULET CORP Insider Trading Activity - Stock Titan
[Form 3] INSULET CORP Initial Statement of Beneficial Ownership - Stock Titan
Why Insulet Corporation stock is rated strong buyEarnings Trend Report & Daily Growth Stock Tips - newser.com
How to interpret RSI for Insulet Corporation stockQuarterly Market Summary & Risk Managed Investment Strategies - newser.com
Tredje AP fonden Has $2.01 Million Position in Insulet Corporation $PODD - MarketBeat
Why Insulet Corporation stock could outperform in 20252025 AllTime Highs & Intraday High Probability Alerts - newser.com
Can Insulet Corporation stock sustain revenue growthQuarterly Market Summary & Stepwise Swing Trade Plans - newser.com
How institutional ownership impacts Insulet Corporation stockJuly 2025 Selloffs & Precise Swing Trade Alerts - newser.com
Simon Quick Advisors LLC Purchases New Position in Insulet Corporation $PODD - MarketBeat
Sector ETF performance correlation with Insulet CorporationMarket Volume Report & Capital Efficient Trading Techniques - newser.com
Will Insulet Corporation stock deliver strong dividend growth2025 Support & Resistance & Risk Managed Investment Strategies - newser.com
Will Insulet Corporation outperform the marketQuarterly Performance Summary & Reliable Price Breakout Signals - newser.com
Why Insulet Corporation stock appeals to dividend seekersRate Cut & Weekly High Potential Stock Alerts - newser.com
What technical signals suggest for Insulet Corporation stockJuly 2025 Outlook & Stepwise Entry/Exit Trade Alerts - newser.com
Why Insulet Corporation (GOV) stock could break out in 2025July 2025 Breakouts & Verified High Yield Trade Plans - newser.com
Amalgamated Bank Purchases 890 Shares of Insulet Corporation $PODD - MarketBeat
Is Insulet Corporation stock a buy before product launchesMarket Risk Report & AI Powered Market Trend Analysis - newser.com
Bessemer Group Inc. Sells 4,287 Shares of Insulet Corporation $PODD - MarketBeat
Envestnet Asset Management Inc. Has $41.99 Million Stock Holdings in Insulet Corporation $PODD - MarketBeat
Will Insulet Corporation rebound enough to break evenWeekly Trade Summary & Community Consensus Trade Signals - newser.com
Finanzdaten der Insulet Corporation-Aktie (PODD)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.91%
0.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):